Hemodynamic Effects of Isoprostanes (8-Iso-Prostaglandin F2α and E2) in Isolated Guinea Pig Hearts
- 1 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 29 (6) , 789-794
- https://doi.org/10.1097/00005344-199706000-00012
Abstract
Isoprostanes are a family of prostaglandin-related compounds formed from arachidonic acid in a cyclooxygenase-independent manner as products of free radical-initiated lipid peroxidation. To elucidate the biological activity of the F2-and E2-isoprostanes, 8-iso-prostaglandin F2α (8-iso-PGF2α) and 8-iso-prostaglandin E2 (8-iso-PGE2), we measured hemodynamic effects in isolated perfused guinea pig hearts after cumulative administration (3 × 10−9-10−5M) of these compounds into the coronary system. Coronary flow (CF), left ventricular pressure (LVP), maximal rate of pressure development (dP/dtmax), and heart rate were determined continuously. Furthermore, net release of lactate into the coronary venous effluent and myocardial pyruvate consumption were measured. Comparative studies were performed with the known potent vasoconstrictor endothelin-1 (6 × 10−12-2 × 10−9M). Both 8-iso-PGF2α and 8-iso-PGE2 induced concentration-dependent decreases in CF, which declined maximally to ∼50% of the baseline level. The potencies of the two compounds were almost identical. Alterations in CF were associated in both groups with parallel reductions of LVP and dP/dtmax; heart rate was not influenced. Furthermore, the diminished CF caused enhanced lactate release and a reduced pyruvate consumption. All isoprostane-induced hemodynamic changes were prevented by coapplication of the thromboxane A2-receptor antagonist SQ 29548 (1 μM). Endothelin-1 caused CF reductions associated with loss of myocardial contractility, just like the isoprostanes. We conclude that in isolated guinea pig hearts, 8-iso-PGF2α and 8-iso-PGE2 are potent vasoconstrictors. The action appears to be mediated by SQ 29548-responsive thromboxane receptors. The accompanying loss of contractility is a secondary phenomenon, elicited by infringed oxygen supply.Keywords
This publication has 18 references indexed in Scilit:
- An Experimental Myocardial Infarction Model in the Rat and Its PropertiesThe Japanese Journal of Pharmacology, 1995
- Familial hemophagocytic lymphohistiocytosis associated with disseminated T-cell lymphoma: A report of two siblingsAnnals of Hematology, 1994
- Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Vascular Smooth Muscle Actions and Receptor Interactions of 8-Iso-prostaglandin E2, an E2-IsoprostaneBiochemical and Biophysical Research Communications, 1993
- Adenosine Contributes to Neutrophil-mediated Loss of Myocardial Function in Post-ischemic Guinea-pig HeartsJournal of Molecular and Cellular Cardiology, 1993
- Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injuryInflammation Research, 1993
- Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.Journal of Clinical Investigation, 1992
- The role of the neutrophil and free radicals in ischemic myocardial injuryJournal of Molecular and Cellular Cardiology, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heartBasic Research in Cardiology, 1982